CLINICAL EFFICACY

Clinical trials of MS-20 on cancer patients have confirmed that it can effectively improve fatigue and loss of appetite caused by chemotherapy, enhancing the ability of cancer patients to maintain family and social activities. The results are significant, with patients taking MS-20 showing much better physical strength, mental state, appetite, and quality of life compared to those who do not take it.

01 /

Effectively improve fatigue symptoms caused by chemotherapy

The group using MS-20 oral solution in combination with chemotherapy showed significant improvement in fatigue symptoms caused by chemotherapy, whereas the control group using chemotherapy alone showed worsening of fatigue symptoms

This trial was evaluated using the Visual Analogue Scale (VAS) for the assessment of cancer patients. The smaller the P (probability) value, the lower the likelihood of exceptions occurring. The result of this trial is p<0.0001, meaning the probability of exceptions occurring is less than 1/10,000.

02 /

Effectively improve and loss of appetite caused by chemotherapy

The group using MS-20 oral solution in combination with chemotherapy showed improvement in loss of appetite symptoms caused by chemotherapy, whereas the control group using chemotherapy alone showed significant worsening of appetite.

This trial was evaluated using the Visual Analogue Scale (VAS) for the assessment of cancer patients. The smaller the P (probability) value, the lower the likelihood of exceptions occurring. The result of this trial is p=0.0005, meaning the probability of exceptions occurring is less than 5/10,000.

03 /

Maintain the ability for family and social activities

The group using MS-20 oral solution in combination with chemotherapy showed improvement in family and social activities in daily life, whereas the control group using chemotherapy alone showed significant worsening.

This trial used the EORTC QLQ-C30 quality of life questionnaire for cancer patients to assess family and social activity levels in various daily activities. The smaller the P (probability) value, the lower the likelihood of exceptions occurring. The result of this trial is p=0.0266, meaning the probability of exceptions occurring is less than 226/10,000.

Taipei City Department of Health Advertisement Approval No. 107090180

PRODUCT INFORMATION

【Indications】 Improve fatigue and loss of appetite in cancer patients treated with chemotherapy.

【Packaging】4 mL in a glass bottle, 14 bottle per box

【Storage Conditions】Store away from light at room temperature.

【Ingredients】 MS-20 oral solution, made from various lactic acid bacteria and yeast. Each mL contains the fermented extract of 2.7 grams of soybean.

【Usage & Dosage】4 mL each time, twice a day. Dilute with 100 mL of warm water and take on an empty stomach.

【Precautions】

Follow the instructions of your doctor, pharmacist, or chemist. If you feel unwell, visit a qualified medical institution or contact your doctor.
This product is for oral use. Drink plenty of water after use.
Solid crystals forming at the bottle mouth or bottom are a natural phenomenon. Remove and dissolve in warm water before drinking.

【Adverse Reactions】

This product is generally safe. In clinical trials, no significant adverse reactions were observed when used with chemotherapy compared to chemotherapy alone.
This product may cause temporary mild constipation or diarrhea, which will improve with continuous use.
If you are sensitive to soybean products, consult your doctor, pharmacist, or chemist before use.

Taipei City Department of Health Advertisement Approval No. 107090180